Diverticular carcinoma of the urinary bladder: diagnosis and treatment problems. A case report

Axel, Hacker; G., Riedasch; Peter, Al Ken; S., Langbein; Maurice Stephan, Michel.
Medical Principles and Practice. 2005; 14 (2): 121-4
en Inglés | IMEMR | ID: emr-73515

Documentos relacionados

  1. Neoadjuvant Dose Dense MVAC versus Gemcitabine and Cisplatin in Patients with cT3-4aN0M0 Bladder Cancer Treated with Radical Cystectomy.
  2. [A case of effective neoadjuvant chemotherapy (MVEC) against right ureteral cancer involving bladder (cT4N1M0)].
  3. Effectiveness and safety of primary prophylaxis of granulocyte colony-stimulating factor during dose-dense chemotherapy for urothelial cancer: Clinical Practice Guidelines for the Use of G-CSF 2022.
  4. [A case of locally advanced squamous cell carcinoma in bladder diverticulum successfully treated by bladder-preserving therapy].
  5. [A CASE OF METASTATIC BLADDER UROTHELIAL CARCINOMA WHOSE DISEASE WAS CONTROLLED FOR A RELATIVE LONG PERIOD BY MULTIDISCIPLINARY TREATMENT INCLUDING RADIATION TO A LUNG METASTASIS AND MULTIPLE COURSES OF CHEMOTHERAPY].
  6. Bladder preservation multimodality therapy as an alternative to radical cystectomy for treatment of muscle invasive bladder cancer.
  7. Population pharmacokinetic analyses of methotrexate in pediatric patients: a systematic review.
  8. Emmprin Expression Predicts Response and Survival following Cisplatin Containing Chemotherapy for Bladder Cancer: A Validation Study.
  9. Do metastatic upper tract urothelial carcinoma and bladder carcinoma have similar clinical responses to systemic chemotherapy? A Japanese multi-institutional experience.
  10. Curative radiotherapy following chemotherapy for invasive bladder carcinoma (a preliminary report).